Correspondence 0001493152-24-043783 from Sonnet BioTherapeutics Holdings, Inc. (SONN) (CIK 0001106838)
Sonnet BioTherapeutics Holdings, Inc. (SONN) (CIK 0001106838)
Date: Nov. 6, 2024 · CIK: 0001106838 · Accession: 0001493152-24-043783
AI Filing Summary & Sentiment
File numbers found in text: 333-282850
Show Raw Text
CORRESP
1
filename1.htm
November
6, 2024
VIA
EDGAR
Securities
and Exchange Commission
Division
of Corporation Finance
100
F Street, N.E.
Washington,
DC 20549
RE:
Sonnet
BioTherapeutics Holdings, Inc. (CIK 0001106838) (the “Company”)
Registration
Statement No. 333-282850 on Form S-1 (the “Registration Statement”)
Ladies
and Gentlemen:
On
November 6, 2024, we, as the representative of the underwriters, filed a letter with the U.S. Securities and Exchange Commission via
EDGAR requesting, pursuant to Rule 461 under the Securities Act of 1933, as amended, the acceleration of the effective date of the above-referenced
Registration Statement so that it may be declared effective at 5:00 p.m., Eastern Time, on November 6, 2024, or as soon practicable thereafter.
We are no longer requesting that such Registration Statement be declared effective at this specific date and time and we hereby formally
withdraw such request for acceleration.
Very
truly yours,
Chardan
Capital Markets, LLC
on
behalf of itself and as representative of the Underwriters
By:
/s/
Shai Gerson
Name:
Shai
Gerson
Title:
Managing
Partner